Bone Marrow Transplant Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Phase 1b/2a Safety and Tolerability of SYN-004 in Allo-HCT Subjects
Condition: 121121000119106, Reduction of the Incidence and/or Severity of Acute Graft-versus-host Reaction Following Bone Marrow Transplant (Disorder) Intervention: Biological: SYN-004, Ribaxamase or Placebo Sponsors: Synthetic Biologics Inc.; Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 31, 2020 Category: Research Source Type: clinical trials
SYN-004 Safety and Tolerability in Allo-HCT Subjects
Condition: 121121000119106, Acute Graft-versus-host Reaction Following Bone Marrow Transplant (Disorder) Intervention: Biological: SYN-004, Ribaxamase or Placebo Sponsors: Synthetic Biologics Inc.; Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 31, 2020 Category: Research Source Type: clinical trials
